(Q33348288)

English

Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jin-Ching Lin

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jian-Sheng Jan

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kuang Y Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Chen-Yi Hsu

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Wen-Miin Liang

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Wen-Yi Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

438-450

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Nasopharyngeal carcinoma: treatments and outcomes in the 20th century

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

21 January 2018

Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

21 January 2018

Management of local residual primary lesion of nasopharyngeal carcinoma (NPC): are higher doses beneficial?

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

21 January 2018

The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: an analysis of 1301 patients

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

21 January 2018

Locally advanced nasopharyngeal cancer: long-term outcomes of radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

21 January 2018

Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced carcinoma of the nasopharynx. 2. Pattern of failure in 256 patients

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Nasopharyngeal carcinoma in Taiwan clinical manifestations and results of therapy

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Partially hyperfractionated accelerated radiotherapy and concurrent chemotherapy for advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Outpatient weekly chemotherapy in patients with nasopharyngeal carcinoma and distant metastasis

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of Epstein-Barr virus DNA in the peripheral-blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis and survival.

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Nasopharyngeal carcinoma: the significance of neck node involvement in relation to the pattern of distant failure

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Concomitant chemoirradiation for stage III-IV nasopharyngeal carcinoma in Chinese patients: results of a matched cohort analysis

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Head and neck cancer: present status and future prospects of adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction chemotherapy followed by concomitant chemoradiation-induced regression of advanced cervical lymphadenopathy in head and neck cancer as a predictor of outcome

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in previously treated patients with advanced/recurrent head and neck cancer: a phase II feasibility study

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN).

1 reference

https://api.crossref.org/works/10.1002%2FHED.10238

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HED.10238

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33348288&oldid=1991379691"